Six numbers in the abstract
Where each one falls
Where it lands on the map
What it changes
the abstract, start to end
… inhibitor (SGLT-2i) [OR, 1.35 (95% CI: 0.81 to 2.25)] or alpha-glucosidase inhibitor (AGI) [OR, 1.16 (95% CI: 0.55 to 2.44)].
… differences ranged from a reduction of -0.30% (95% CI: -0.55 to -0.05) for …
… risk of hypoglycemia, except Met [OR, 0.58 (95% CI: 0.29 to 1.18)] and …
… agents combined with SU, ranging from -2.77 mmol/l (95% CI: -4.14 to -1.40) …
… and DPP-4i, with changes ranging from -2.91 kg (95% CI: -4.15 to -1.68) for …
← favours treatmentfavours comparator →
could be chanceHypoglycaemia
OR 1.350.81–2.25
Hypoglycaemia
OR 1.160.55–2.44
Glycemic control
−0.30−0.55 to −0.05
Hypoglycaemia
OR 0.580.29–1.18
Glycemic control
−2.77−4.14 to −1.40
Body weight & composition
−2.91−4.15 to −1.68
MetforminSulfonylureas & glinidesOther glucose-loweringGlycemic controlBody weight & compositionHypoglycaemia
Other glucose-lowering × hypoglycaemiaharms?mixed
unlikelylikely
0.00not counted
1 / 4